Photodynamic therapy, employing either hematoporphyrin derivative or dihematoporphyrin ether as the photosensitizer and an argon-pumped tunable dye laser as the activating light source, was used to treat ten patients who had primary or recurrent basal or squamous cell carcinoma or infiltrating ducta
[5.03] Photodynamic therapy for the treatment of pathogen bacteria
✍ Scribed by Emina Besic; Martin Lüthi; Rudolf Gmür; Klaus Grätz; Heinrich Walt; Caroline Maake
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 66 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1615-1615
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Photodynamic therapy (PDT) is an FDA‐approved minimally invasive medical treatment modality that utilizes light in the presence of oxygen to activate photosensitizing agents that are relatively selectively concentrated in abnormal or neoplastic cells resulting in cell death. At the pres
The photodynamic therapy of superficial vocal cord carcinoma is a promising new technique. Patients were irradiated with 630 nm light from an Aurora dye laser under general anaesthesia 72 h after a haematoporphyrin derivative (HpD) injection. So far, 32 patients have been treated for small epidermoi
## Abstract ## Background and Objective We utilized photodynamic therapy (PDT) for palliation of metastatic endobronchial tumors employing sensitization with synthetic porphyrin, application of non‐thermal light, and endoscopic debridement of necrotic tumor. ## Study Design/Materials and Methods
Background and Objective: Synovectomy of small joints is a therapeutic approach in patients suffering from rheumatoid arthritis (RA). We examined the feasibility of transdermal photodynamic therapy (tPDT) in a fibroblast-induced model of joint destruction using the novel photosensitizer (PS) tetrahy